Literature DB >> 8163269

Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.

Y Tashiro1, S Yonezawa, Y S Kim, E Sato.   

Abstract

Many of the cancer-associated antigens recently have been identified as mucin antigens. However, there are no detailed studies describing the expression of carbohydrates and core proteins of mucin antigens in ovarian tumors. In this study we examined the expression of carbohydrate antigens, which are associated with the earliest steps in mucin glycosylation (Tn and sialosyl-Tn), and the expression of the mucin core protein antigens associated with the MUC1 gene product (mammary-type apomucin) and the MUC2 gene product (intestinal-type apomucin) in 123 ovarian epithelial (mucinous and serous) tumors. In normal ovarian tissues neither Tn, sialosyl-Tn, nor intestinal-MRP antigens (MUC2 gene product) were expressed, except for positive sialosyl-Tn staining of stromal capillaries, while the MUC1 gene product, DF3 antigen, was expressed in the cell apex of the germinal coelomic epithelium when it had plump, slightly elongated, or pseudostratified nuclei. In the benign adenomas Tn and sialosyl-Tn antigens were detected in a small number of mucinous adenomas and rarely in serous adenomas. In contrast, expression of both Tn and sialosyl-Tn antigens was observed in all the adenocarcinomas and in a considerable number of borderline malignancies. DF3 antigen was expressed in many benign serous tumors but not so frequently in benign mucinous tumors; however, it was frequently expressed in the adenocarcinomas and borderline malignancies of both mucinous and serous types. Intestinal-MRP antigen expression increased with the transition of the mucinous tumors from a benign to malignant state, although it was never detected in the serous tumors. Coexpression of DF3 and intestinal-MRP antigens was seen in borderline malignancies and carcinomas of the mucinous tumors. In conclusion, simultaneous expression of Tn and sialosyl-Tn antigens is a highly effective tumor marker in both mucinous and serous tumors of the ovary. Coexpression of DF3 and intestinal-MRP antigens may indicate the malignant potential of ovarian mucinous tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163269     DOI: 10.1016/0046-8177(94)90144-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.

Authors:  Y Cao; P Stosiek; G F Springer; U Karsten
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

Review 2.  Primary retroperitoneal mucinous cystadenocarcinoma in a male patient.

Authors:  T P Thamboo; R Sim; S-Y Tan; W-M Yap
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

3.  Analysis of Recombinant CD24 Glycans by MALDI-TOF-MS Reveals Prevalence of Sialyl-T Antigen.

Authors:  Edwin Motari; Xincheng Zheng; Xiaodan Su; Yang Liu; Mamuka Kvaratskhelia; Michael Freitas; Peng George Wang
Journal:  Am J Biomed Sci       Date:  2009-01-01

4.  Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics.

Authors:  Tongxia Wang; Yan Gao; Xi Wang; Junrui Tian; Yuan Li; Bo Yu; Cuiyu Huang; Hui Li; Huamao Liang; David M Irwin; Huanran Tan; Hongyan Guo
Journal:  Chin J Cancer Res       Date:  2022-04-30       Impact factor: 4.026

5.  Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.

Authors:  Renu Rathee; Anju Devi; Anjali Narwal; Mala Kamboj; Sunita Singh
Journal:  Head Neck Pathol       Date:  2021-02-05

6.  Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.

Authors:  Rita Pinto; Ana S Carvalho; Tim Conze; Ana Magalhães; Gianfranco Picco; Joy M Burchell; Joyce Taylor-Papadimitriou; Celso A Reis; Raquel Almeida; Ulla Mandel; Henrik Clausen; Ola Söderberg; Leonor David
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

7.  Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation.

Authors:  Cameron Beech; Mollie Freedman-Weiss; Ronald Salem; Dhanpat Jain; Xuchen Zhang
Journal:  Gastroenterology Res       Date:  2019-08-25

8.  Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.

Authors:  Kenichi Hirabayashi; Masanori Yasuda; Hiroshi Kajiwara; Johbu Itoh; Masaki Miyazawa; Takeshi Hirasawa; Toshinari Muramatsu; Masaru Murakami; Mikio Mikami; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-04-26       Impact factor: 1.938

9.  Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas.

Authors:  Sung-Im Do; Kyungeun Kim; Dong-Hoon Kim; Seoung Wan Chae; Yong Lai Park; Chan Heun Park; Jin Hee Sohn
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

10.  High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.

Authors:  Yi-feng He; Mei-ying Zhang; Xin Wu; Xiang-jun Sun; Ting Xu; Qi-zhi He; Wen Di
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.